Home › Therapeutic areas › Oncology › Renal Cell Carcinoma
Renal Cell Carcinoma (8 companies)
Companies with an active program in Renal Cell Carcinoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics | ImmunologyOncology Rare | 1 | Phase 2 | 10 |
| RCUS | Arcus Biosciences | DermatologyImmunology+1 | 2 | Phase 3 | 6 |
| CMPX | Compass Therapeutics | Oncology | 1 | Phase 2 | 15 |
| CRVS | Corvus Pharmaceuticals | DermatologyOncology Rare | 1 | Phase 3 | 6 |
| EXEL | Exelixis | CardiovascularOncology | 3 | Approved | 21 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | 12 |
| NVCT | Nuvectis Pharma | HematologyOncology+1 Rare | 1 | Phase 3 | 8 |
| XNCR | Xencor | ImmunologyNeurology+1 Rare | 3 | Approved | 28 |
No companies match.